Drugs News and Research

RSS

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Researchers identified curcumin derivatives as potential inhibitors of SARS-CoV-2 enzymes.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

Novel method can help find the most appropriate exercise therapy for osteoarthritis patients

Osteoarthritis is the most common cause of chronic pain and disability in the world. While no good structure modifying drugs are available to prevent or treat osteoarthritis, various forms of therapeutic exercise have been shown to be useful in relieving pain and improving physical functionality.

16 Mar 2022

INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research

Scientists at Rejuveron Vascular Therapeutics AG, a company specializing in the development of therapies to tackle neurodegeneration, are using INTEGRA’s VIAFLO 384 handheld electronic pipette to accelerate their research.

From INTEGRA Biosciences 16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

Discovery of key brain pathway offers potential new drug target for treating anxiety

A new target in the brain which underpins the eliciting of anxiety and fear behaviors such as 'freezing' has been identified by neuroscientists.

15 Mar 2022

Nanoparticle-enhanced phototherapies for cancer treatment

Treating cancer and other diseases with laser light is not currently considered routine in the clinical setting, but new approaches using nanoparticles show some promise in improving existing techniques.

15 Mar 2022

Pathogen works with drug to clear fungal infection, study shows

Pathogens don't always work against drug treatments. Sometimes, they can strengthen them, according to a new University of Maine study.

15 Mar 2022

Survey reveals severe shortage of pharmacy technicians in hospitals and health systems

Hospitals and health systems are experiencing severe shortages of pharmacy technicians, with a majority of pharmacy administrators in a recent survey reporting turnover rates of at least 21% in 2021, and nearly 1 in 10 noting they had lost 41% or more of their technicians.

15 Mar 2022

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Stand Up To Cancer and Zentalis Pharmaceuticals, Inc. today announced that Zentalis will contribute $1 million to the SU2C Catalyst program to support research that investigates the use of certain small molecule inhibitors for treating a variety of cancer types.

15 Mar 2022

Orally-active senolytics can boost a key beneficial protein in mice and humans

Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that protects older people against aspects of aging and a range of diseases.

15 Mar 2022

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Different activity in two molecular networks could help explain why triple negative breast cancers tend to be more aggressive in African American (AA) women compared with white American (WA) women, a new study led by Johns Hopkins Kimmel Cancer Center researchers suggests.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Lillian Karabaic teaches personal finance to millennials through a podcast and community called Oh My Dollar! — and she needs an expensive drug to treat a chronic condition.

15 Mar 2022

Study results in three new co-amorphous drug systems with great anti-COVID-19 potential

Researchers demonstrated that the bioavailability of matrine-type alkaloids could be prolonged by employing a co-former, resveratrol.

15 Mar 2022

‘Foreign body reaction’ to implants can be reduced by incorporating drug into silicone coating

Long-term use of implantable electronic medical devices – such as pacemakers and cochlear implants – is hampered by the body's reaction to foreign bodies.

14 Mar 2022

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

RSV is a leading cause of severe acute lower respiratory tract infections (LRTIs) among infants globally, and a prominent contributor to common non-severe infections that account for high volumes of antibiotic consumption.

14 Mar 2022

UNC researchers offer solution to detect, issue warnings about tainted street drugs

With new grant funding, Nabarun Dasgupta '13 (Ph.D.), Gillings Innovation Fellow at the UNC-Chapel Hill Gillings School of Global Public Health and senior scientist at the UNC Injury Prevention Research Center, will work with colleagues across Carolina to develop systems to detect and issue public warnings about dangerous adulterants in street drugs.

14 Mar 2022

New smartphone app can calculate users’ genetic risk for coronary artery disease

A Scripps Research team developed a smartphone app that can calculate users' genetic risk for coronary artery disease (CAD) - and found that users at high risk sought out appropriate medication after using the app.

14 Mar 2022

Malaria drug could help treat chemotherapy-resistant head and neck cancers

A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.

14 Mar 2022

Drugs News and Research

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

Novel method can help find the most appropriate exercise therapy for osteoarthritis patients

INTEGRA’s VIAFLO 384 proves indispensable in neurodegeneration research

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Discovery of key brain pathway offers potential new drug target for treating anxiety

Nanoparticle-enhanced phototherapies for cancer treatment

Pathogen works with drug to clear fungal infection, study shows

Survey reveals severe shortage of pharmacy technicians in hospitals and health systems

Zentalis contributes $1 million to SU2C Catalyst program for research into targeted cancer therapeutics

Orally-active senolytics can boost a key beneficial protein in mice and humans

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

High doses of antibiotic may safely and effectively treat TB meningitis

‘An Arm and a Leg’: Need an expensive drug? Here’s what you need to know

Study results in three new co-amorphous drug systems with great anti-COVID-19 potential

‘Foreign body reaction’ to implants can be reduced by incorporating drug into silicone coating

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

UNC researchers offer solution to detect, issue warnings about tainted street drugs

New smartphone app can calculate users’ genetic risk for coronary artery disease

Malaria drug could help treat chemotherapy-resistant head and neck cancers

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News